Mediar Therapeutics
United StatesEntry
2021
Hold
5yr
Status
Active
Who owns Mediar Therapeutics?
Mediar Therapeutics is an American Biotech company, currently owned by Sofinnova Partners since 2021 and Gimv.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Sofinnova PartnersSofinnova Capital X · 2021 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
Sofinnova PartnersActive
2021 · present(5yr) · Sofinnova Capital X · 2021 · Life Sciences VC
GimvActive
2021 · present(5yr) · Gimv Portfolio
More from Sofinnova Capital X
Other portfolio companies in the same fund.
Germany
Denmark
France
Spain
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Mediar Therapeutics?
Mediar Therapeutics is currently owned by Sofinnova Partners and Gimv, through Sofinnova Capital X, since 2021.
When did Sofinnova Partners and 1 other acquire Mediar Therapeutics?
Sofinnova Partners and 1 other acquired Mediar Therapeutics in 2021.
Who has owned Mediar Therapeutics over time?
Mediar Therapeutics has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital X · since 2021; Gimv · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue